The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlle…

Overview of attention for article published in BMJ Open, October 2013

Altmetric Badge

Mentioned by

peer_reviews: 1 peer review site

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 86 Mendeley

Summary Peer reviews Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52‐week randomized controlled clinical trial

Article in Diabetes Obesity and Metabolism (October 2023)

Identification of differentially expressed genes and signaling pathways in gestational diabetes mellitus by integrated bioinformatics analysis

Preprint in bioRxiv (November 2021)

One Year’s Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

Article in Journal of Clinical Medicine (October 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.